Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects.
نویسندگان
چکیده
CONTEXT Insulin reportedly impairs endothelial function in conduit arteries but improves it in resistance and microvascular arterioles in healthy humans. No studies have assessed endothelial function at three arterial levels in healthy or metabolic syndrome (METSYN) subjects. OBJECTIVE The objective of the study was to compare endothelial responsiveness of conduit arteries, resistance, and microvascular arterioles to insulin in healthy and METSYN subjects. DESIGN We assessed conduit, resistance, and microvascular arterial function in the postabsorptive and postprandial states and during euglycemic hyperinsulinemia (insulin clamp). SETTING The study was conducted at a clinical research unit. PARTICIPANTS Age-matched healthy and METSYN subjects participated in the study. INTERVENTIONS We used brachial flow-mediated dilation, forearm postischemic flow velocity, and contrast-enhanced ultrasound to assess the conduit artery, resistance arteriole, and microvascular arteriolar endothelial function, respectively. We also assessed the conduit artery stiffness (pulse wave velocity and augmentation index) and measured the plasma concentrations of 92 cardiovascular disease biomarkers at baseline and after the clamp. RESULTS Postabsorptive and postprandial endothelial function was similar in controls and METSYN in all tested vessels. METSYN subjects were metabolically insulin resistant (P < .005). In controls, but not METSYN subjects, during euglycemic hyperinsulinemia, endothelial function improved at each level of arterial vasculature (P < .05 or less for each). Conduit vessel stiffness (pulse wave velocity) was increased in the METSYN group. Twelve of 92 biomarkers differed at baseline (P < .001) and remained different at the end of the insulin clamp. CONCLUSIONS We conclude that insulin enhances arterial endothelial function in health but not in METSYN, and this vascular insulin resistance may underlie its increased cardiovascular disease risk.
منابع مشابه
[Effects of rosiglitazone on endothelial function in non-diabetic subjects with metabolic syndrome].
OBJECTIVE To evaluate the effects of rosiglitazone (ROSI), an insulin-sensitizer, on endothelial function and endothelial activation markers in a group of non-diabetic subjects with metabolic syndrome. METHODS A group of eighteen subjects (12 women, 6 men), mean age 41.2 +/- 9.7 and BMI 37.8 +/- 6.1 Kg/m2, was treated with rosiglitazone 8 mg/day for 12 weeks. Another group of nine healthy sub...
متن کاملتأثیر اختلالات گلوکز ناشتا روی فاکتورهای عملکرد اندوتلیال و شاخصهای بیوشیمیایی در بیماران مبتلا به سندرم متابولیک
Background & Aims: Endothelial dysfunction is found in early steps of atherosclerosis and is related with diseases such as hypertension, dyslipidemia, and insulin resistance. Insulin resistance is related to metabolic abnormalities .We aimed to examine influence of impaired fasting glucose on endothelial function biomarkers and biochemistry biomarkers in metabolic syndrome patients.Materials &...
متن کاملThe Association Between Metabolic Syndrome and Serum Leptin
Objectives: The relation of metabolic syndrome components, insulin resistance and leptin has been studied in elderly women. Methods & Materials: In this cross sectional study, among 225 subjects≥60 year old who were residents of Kahrizak Charity Foundation, 133 (56 men & 77 women) were selected by cluster random sampling. Fasting serum TG, Total Cholesterol, HDL, and leptin levels were measu...
متن کاملStudy of pulmonary functions in patients with metabolic syndrome
Introduction: Metabolic syndrome (MetS) and impaired lung functions have been associated with an increased risk for coronary heart disease. The aim of this study was to investigate the pulmonary functions in patients with MetS. Methods: This cross-sectional study included 200 subjects with MetS in the study group and 100 subjects without MetS in the control group. Participants were examined...
متن کاملChronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome.
The possible contribution of tumor necrosis factor-α (TNF-α) to the development of obesity-associated insulin resistance in humans is still controversial. Our study investigated the effect of TNF-α neutralization on insulin resistance in healthy, obese and insulin resistant men. We performed a prospective, randomized, double-blind placebo-controlled trial in nine young, healthy obese male subje...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of clinical endocrinology and metabolism
دوره 101 3 شماره
صفحات -
تاریخ انتشار 2016